|
Pfizer Chair & CEO Albert Bourla, DVM, PhD to Welcome Attendees to the 27th Pharma & Device Ethics & Compliance Congress
|
- A Hybrid Onsite Conference and Internet Event
- The Leading Forum on Pharmaceutical and Medical Device Ethics and Compliance Issues
- Sponsored by Pharmaceutical Compliance Forum
- October 13-16, 2026
- Washington Hilton, Washington, DC
- www.PharmaCongress.com
PRESS RELEASE
Phone: 800-503-7419
Email: reginfo@hcconferences.com
Website: www.PharmaCongress.com
|
|
INDIVIDUAL AND GROUP REGISTRATION
|
Register by September 18 for Early Bird
Click here to register individuals or groups.
|
|
HILTON GROUP GUEST ROOM DISCOUNT ENDS ON 9/3
|
Click here for Group Rate of
$289 until Thursday 9/3.
|
|
|
FEATURING C-SUITE CONGRESS WELCOME BY
|
Albert Bourla, DVM, PhD
Chairman & CEO, Pfizer; Former Chair, Pharmaceutical Research & Manufacturers of America (PhRMA); Former President, International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), New York, NY
|
|
WASHINGTON, DC USA -- PHARMA UPDATE NEWS SERVICE™ -- AUGUST 20, 2026: The Twenty-Seventh Annual Pharmaceutical & Medical Device Ethics and Compliance Congress sponsored by the Pharmaceutical Compliance Forum (PCF) will be held at the Washington Hilton, Washington, DC on October 13-16, 2026. Attendees may attend either virtually online or in person. Onsite attendees will also enjoy both live and post-conference access to the Congress audio/video archive.
|
|
THE 2026 27TH ANNUAL CONGRESS FEATURES
|
- New half-day Focused Sessions on the afternoon of Tuesday 10/13
- Over 50 concurrent mini summits and 15 plenary session presentations
- The PCF-sponsored, Closed-door, invitation-only CCO Roundtable, last year attended by over 100 CCOs
- The Industry-only Compliance Best Practices Think Tank hosted by PCF
- A sold-out exhibit hall featuring many innovative ethics and compliance products, programs and initiatives
- Numerous professional networking opportunities
|
|
GOVERNMENT KEYNOTE SPEAKERS
|
Jacob Foster, JD
Acting Chief, Health Care Fraud Unit, Criminal Division, Fraud Section, US Department of Justice, Washington, DC |
Veronika Peleshchuk Fradlin, MPP
Director, Transparency & Data Group, Centers for Medicare & Medicaid Services, US Department of Health and Human Services, Washington, DC |
Brenna Jenny, JD, MPH
Deputy Assistant Attorney General, Commercial Litigation Branch, Civil Division, US Department of Justice, Washington, DC
|
Twyla Mosey, PharmD, RPh
Director, Division of Advertising & Promotion Review, US Food and Drug Administration, Washington, DC |
Mary E. Riordan, JD
Senior Counsel to the Inspector General, HHS Inspector General, Washington, DC
|
|
THE ANNUAL ADVAMED, BIO & PHRMA UPDATE BY
|
John Delacourt, JD
Deputy GC, VP Health, Regulatory & Commercial Operations, BIO; Former Chief Antitrust Counsel, FTC, Washington, DC |
Ida Nassar, JD
VP, Assistant General Counsel, Ethics & Compliance, AdvaMed; Former Senior Attorney, Office of Chief Counsel, US DEA, Washington, DC |
Julie Ritchie Wagner, JD
Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Washington, DC
|
|
A QUI TAM COUNSEL ROUNDTABLE BY
|
Mary A. Inman, JD
Partner, Whistleblower Partners; Founding Member & Board Chair, Psst.org; Member of Advisory Board, Whistleblowing Canada Research Society, San Francisco, CA |
Linda Severin, JD
Managing Member, Whistleblower Law Collaborative LLC; Former Assistant US Attorney, Southern District of New York, US DPJ, Boston, MA |
Gregg Shapiro, JD
Founder, Gregg Shapiro Law, LLC; Former Assistant US Attorney and Chief, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, US DOJ, Boston, MA
|
|
ETHICS & COMPLIANCE PROFESSIONALS AND IN-HOUSE COUNSEL
|
Peter Agnoletto, CPA
Compliance Officer, General Medicines and Consumer Health Care, Sanofi, Bridgewater, NJ |
Kaoutar Afif
Manager, Ethics & Compliance, Cardinal Health, Dublin, OH |
Brian C. Barry, JD
Vice President, Chief Compliance Officer, Vertex; Former Compliance Officer, US & Canada, EMD Serono, Boston, MA
|
Allison Benkert, MBA
Sr. Director, Compliance Policies, Training & Investigations, Jazz, Doylestown, PA |
Amy Bensten, JD
Head of Investigations for Americas, Ethics & Compliance, Takeda, Cambridge, MA |
Brent Boeckmann, MBA
Strategic Advisor, Commercial Immunology, Sanofi; Fmr VP, Eli Lilly - Inproteo Affiliate, Boston, MA
|
Peter Brensilver, JD
Senior Vice President, Chief Global Commercial Compliance & Risk Counsel, Pfizer, New York, NY |
Terra Buckley, JD
Chief Compliance & Ethics Officer, Bristol Myers Squibb; Fmr CCO, LivaNova, Summit, NJ |
Sri Burra, MBA
Director, US Ethics & Compliance, Organon; Fmr Ethics & Compliance Lead, NA, Haleon, Malvern, PA
|
Briana Cabrera, MS, CFE
Senior Director, Global Privacy, Medtronic; Fmr Director, Forensic Audit, Covidien, Miami, FL |
Regina Cavaliere, JD
Chief Ethics & Compliance Officer, VP Regulatory & Compliance, Henry Schein, Melville, NY |
Maureen Cawley, JD
Senior Director, Corporate Counsel, Incyte; Fmr Global Agreements Attorney, Merck, Philadelphia, PA
|
Jessica Constant, MS
Associate Director, Compliance, AstraZeneca; Fmr Global Compliance Business Partner, QIAGEN, Washington, DC |
Elizabeth Conti, JD
Senior Legal Counsel, Nestlé Health Science, Arlington, VA |
Reetu Dandora, JD
SVP, Quality & Regulatory Compliance, AVEO; Fmr Executive Director Strategic Quality Oversight, Merck, Boston, MA
|
Giulia Del Cane, MS
Head, E&BI Projects & Compliance Officer, Enabling Functions, Global Specialty Care, Sanofi, Boston, MA |
Sharon R. Delshad, JD
Senior Director, Legal-Compliance Counsel, Travere Therapeutics; Founder, Rebel Compliance, Del Mar, CA |
Jason DiPietro
Senior Manager Compliance Analytics & Transparency Compliance, Lundbeck, Lake Zurich, IL
|
Colleen Doyle, ACFE
Senior Director, Risk Insights, Novo Nordisk; Fmr Senior Director, Compliance, Sage, Plainsboro, NJ |
Jennifer Dubas, JD
CCO, Jazz; Fmr SVP & CCO, Concore; Fmr SVP & CCO, AmerisourceBergen, Ambler, PA |
Katherine Dyson, JD
Head of US Compliance, Alexion; Fmr Head of Assurance, Alexion, AstraZeneca, Boston, MS
|
Kevin Espinoza, MBA
Chief Integrity & Compliance Officer, Indivior; Fmr CCO, Kaleo; Fmr SVP, Boston Scientific, Richmond, VA |
Patrice Ettinger, JD, CIPP/US
VP, CPO, Regeneron; Fmr CPO, Pfizer; Fmr CPO, Avon, New York, NY |
Yelena Ferreira, JD
Assistant GC & Head of Compliance, Pharmacosmos; Fmr Senior Director, AGC, Pacira, Morristown, NJ
|
Susana Franco, MBA
Director, Field Compliance, Lundbeck; Fmr Director, Compliance Operations, Orthofix, Dallas, TX |
Rawan Fusisi
Head, Transparency and Third Party Compliance, Indivior; Fmr Transparency and Analytics Manager, Stryker, Washington, DC |
Julian Gabbard, JD
Associate GC, Meso Scale; Fmr Head of Legal & Compliance, Kolon; Fmr Sr. Director, Arcellx, Washington, DC
|
Naveen Ganesh, MA, JD
VP, Global Head of Investigations, Takeda; Fmr Head of Investigations, North America & Global Specialty Care, Sanofi, Boston, MA |
Jeanille Gatta, MA
Director, Compliance Business Partner, AstraZeneca, North America, Philadelphia, PA |
Lindsey LaMoria Gavin
Senior Director, Deputy Compliance Officer, Lundbeck; Fmr Compliance Director, Meetings & Events International, Deerfield, IL
|
Jim Gibney
Vice President, Global Compliance Operations, Regeneron; Fmr Director, Worldwide Programs, Pfizer, Ridgewood, NJ |
Jillian A. Gillespie, MBA
Sr. Director, Compliance, Medical & Medical Affairs, Pfizer; Fmr Director, Compliance Business Partner, Seagen, Chicago, IL |
Betania Glorio, JD
SVP & CCO, Avidity; Fmr CCO & Head, Group Compliance & Data Privacy, EMD Serono, Boston, MA
|
Kate Godfrey, JD, CCEP
SVP, Global Chief Compliance Officer, Karl Storz North America, El Segundo, CA |
Kimberly Gold, JD
CPO & Senior AGC, Privacy Law, Genentech; Fmr Privacy Secondee, Pfizer, San Francisco, CA |
Michele Guerino, MS
Executive Director, Ethics and Compliance Officer, Merck; Fmr Senior Regional Business Director, Cubist, Hopewell, NJ
|
Tracey Hannon, JD
Director, Compliance Business Partner, Alexion; Fmr Compliance Counsel, Ionis, Boston, MA |
Kathryn Harris, JD
Head, US Compliance, Galderma; Fmr Senior Director, Global Compliance, Emergent, Boston, MA |
Laura E. Heyduk
Vice President, Head of Global Compliance, KalVista; Fmr Head, US Compliance, Biogen; Fmr Compliance Director, Insulet, Cambridge, MA
|
Stefanie L. Hill, JD
Senior Director, Global Ethics & Compliance, Emergent; Fmr Senior Compliance Counsel, Prolacta, Gaithersburg, MD |
Tom Hiney, JD
Head, Digital Ethics, US Business Unit, Takeda; Fmr Privacy Counsel, Blueprint, Boston, MA |
Marla Izbicky, JD
Senior Director, Senior Corporate Counsel, Harmony Biosciences, Chicago, IL
|
Tahvia Jenkins, JD, CIPPUS
US Privacy Officer & Counsel, Sanofi; Fmr Assistant Counsel, University of California, Cambridge, MA |
Kathy Johnson, JD
Vice President, Commercial and Development Legal, Vertex; Fmr, US Legal Counsel Consultant, Takeda, Boston, MA |
Melissa (Missy) Kaschak, MS, CPA, CFE, CISA
GRC Operations, Olympus Corporations of the Americas, Center Valley, PA
|
Abe Kassis, MBA, PhD
Global Head Compliance & Legal, Bausch + Lomb; Fmr Global Compliance Director, Takeda, New York, NY |
Geeta Kaveti, MHA, JD
CCO & US General Counsel, Nyxoah; Fmr VP, Chief Compliance & Privacy Officer, Nevro, Vernon Hills, IL |
Jeffrey Kawalek, MBA
Chief Compliance Officer, Zambon US; Fmr Deputy CCO US, Jazz; Fmr Board Chair, PCF, New York, NY
|
Peggy Kruk, HMCC
Compliance Manager, MiMedX; Fmr Director, Compliance, Program Services, Vaniam Group, Dallas, GA |
Cheryl Lee, MBA, CHC
Head of Compliance, Cycle; Fmr VP, ESG Strategy & Execution, BMS; Fmr VP, Compliance Worldwide, Celgene, New York, NY |
Peter Lee, JD, LLM
Chief Compliance Officer, Kura Oncology; Fmr CCO, Mirati Therapeutics; Fmr CCO, Heron Therapeutics, San Diego, CA
|
Aaron Lewis, MBA
Director, Legal & Compliance, Cordis; Fmr Director, Compliance Insights, Cardinal Health, Miami Lakes, FL |
Melissa T. Lozner, JD
Senior VP, CCO, Regeneron; Fmr CCO, Rafael Holdings; Fmr VP, Ethics, Novartis, Tarrytown, NY |
Christian Malias, MBA
Assoc. Director, Compliance Program, Insmed; Fmr Assoc. Director Compliance, Sage, Pittsburgh, PA
|
Danielle Manner, JD
Chief Privacy Officer and Senior, Associate General Counsel, Gilead; Fmr Senior Privacy Counsel, Pfizer, Chicago, IL |
Aaron P. Mastery, CPA
Senior Director, Compliance Operations, Mighty; Fmr Director, Compliance Auditing & Monitoring, Idorsia, Wilmington, DE |
Rosemary McKenna, JD
Executive Director, Regulatory Legal, Organon; Fmr Director, Regulatory-Legal, Merck, Philadelphia, PA
|
Nick Merker, JD
Vice Preesident, Assistant General Counsel, Chief Privacy Officer & Head of Digital Legal Office, Eli Lilly, Indianapolis, IN |
Fabiana Morette-Lattea, LLM, LLB
Global Compliance Program Lead, Telix; Fmr Associate Director, Compliance, Merck, Indiana, IN |
Michael Morgan, MBA, CCEP
Global Compliance Officer, Telix; Fmr Ethics and Compliance Officer-North America, Corteva, Indianapolis, IN
|
Michelle Murphy
Executive Director, Compliance, Regeneron; Former Consultant, Musculoskeletal Transplant Foundation, New York, NY |
Meghan Naas, MA
Corporate Compliance Officer, Innoviva Specialty Therapeutics; Fmr Head of Corporate Compliance, Adaptimmune, Waltham, MA |
Eric Ortman, MBA
Senior Director, Legal Operations Compliance, 4D Molecular; Fmr Senior Director, Legal Operations, BeiGene, Walnut Creek, CA
|
Alison Page, JD
Assistant General Counsel, Pfizer, New York, NY |
Al Park
Senior Compliance Officer, Global Monitoring & Auditing, Jazz; Fmr Global Program Effectiveness, Amgen, Phoenix, AZ |
Sandra Park, JD
Senior Vice President, Legal & CCO, Vera; Fmr GC & CCO, IDEOlogy Health; Fmr VP, Commercial Legal, Kite, a Gilead Company, Brisbane, CA
|
Samantha Brabant Philis, CCEP
Director, E&C Policy, Training & Business Operations, Jazz; Fmr Sr Manager, Office of Ethics & Compliance, Medline Industries, Chicago, IL |
Joan Podleski, CCEP, CHPC, CHRC, CHC
VP & CPO, Children's Health System of Texas; Fmr Director, Institutional Ethics & Compliance Program, Duke University, Dallas, TX |
Lauren Ann Pond, JD
Assistant General Counsel, BridgeBio; Fmr Commercial Counsel, Biogen; Fmr Counsel, Takeda, Palo Alto, CA
|
Hannah Putnam, MHA
Head of Ethics & Compliance Operations, Oncology, Takeda; Fmr Senior Director, Ethics & Compliance, Veloxis, Cambridge, MA |
Ariadna Quesada, MSJ
VP, Compliance, Global Compliance & Privacy, ZOLL; Fmr Compliance Director, Europe & MEATI, Hillrom, Madrid, Spain |
Omar Richardson, MBA
Executive Director, Compliance, Shionogi; Fmr Compliance Officer, Grünenthal, New York, NY
|
Roberta Rima, MS
VP, Global Compliance Audit, Monitoring & Analytics, Zimmer Biomet; Fmr Sr Director, Gilead, San Francisco, CA |
Megan Roberts, CPA, MS
Head, Integrity & Compliance, Par Health; Fmr Senior Director, Integrity, Mallinckrodt, St. Louis, MO |
Jaya Saigal
Senior Director, C&E Policy, Education, Communications, Culture of Integrity and Ombuds, BMS, Princeton, NJ
|
Monica Schroeter, CPA, CISA
Head of Compliance Operations and Risk, LivaNova; Fmr Head of Compliance & Privacy, SK Life Sciences, Goshen, NY |
Christian Scognamillo, JD
Associate GC, US Market Access & Pricing, Abbvie; Fmr Senior Corporate Counsel, Market Access, Exelixis, San Francisco, CA |
Alexis Shaw, ACFE
Deputy CCO, Paratek; Fmr Global Compliance Investigations Manager, Boston Scientific, King of Prussia, PA
|
R. Brett Short, CHC, CHPC, CHRC
CCO & CPO, University of Kentucky; Past Chair, Health Care Compliance Association, Lexington, KY |
Jesse Siegel, JD
Head of Business Ethics, Americas, Ipsen; Fmr Senior Counsel, Neurology & Immunology, EMD Serono, Cambridge, MA |
Matthew Stasiunas
RAMP & Project Management Lead, Indivior; Fmr Senior Specialist, Integrity & Compliance, Kaléo, Richmond, VA
|
Ronald Strauss, CIPM
Vice President Compliance, MiMedx; Fmr Sales Leader, Eli Lilly Specialty, Marietta, GA |
Kelly J. Tope, JD, MBA
Head, Ethics & Business Integrity Governance, Sanofi; Fmr Head, USBU Ethics & Compliance, Takeda, Boston, MA |
Emily Treanor, JD
Head of Global Investigations, Alnylam; Fmr Senior Legal Counsel, Global Compliance, Hess, Washington, DC
|
Natasha Trifun, JD
Head of Enterprise Compliance & Risk and Privacy, AstraZeneca; Fmr Corporate Counsel, Brazil Compliance Officer, Pfizer, Boston, MA |
Akosua Tuffour-Brown, JD
Corporate Counsel, U.S. General Medicines, Sanofi, Washington, DC |
Betsy Wade, MPH, CHC, CHPC, CAN
Chief Compliance & Ethics Officer, Signature Healthcare; Board & Treasurer, Health Care Compliance Association, Louisville, KY
|
|
|
|
INDIVIDUAL AND GROUP REGISTRATION
|
Register by Sep. 18 for Early Bird
Click here to register individuals or groups.
|
|
HILTON GROUP GUEST ROOM DISCOUNT ENDS ON 9/3
|
Click here for Group Rate of
$289 until Thursday 9/3.
|
|
UPDATED AGENDA
|
|
Click here for Agenda.
|
|
SPONSORED BY
|
|
|
PRODUCED BY
|
|
|
PCF BOARD
|
Donna White, CCEP
Vice President and Compliance Officer, Chiesi Farmaceutici S.p.A., Americas Region (Board Chair)
Christie Camelio
Senior Vice President and Chief Compliance Officer, Insmed
Jill Dailey, JD
Vice President & Chief Compliance Officer, Oncology, Menarini Stemline
Anisa Dhalla
Vice President, Global Head, Ethics and Business Integrity, UCB
Daryl Kreml, JD
Head of Ethics & Compliance, Global Oncology, Takeda
Melissa T. Lozner, JD
Senior Vice President, Chief Compliance Officer, Regeneron
|
|
MEDICAL DEVICE EXECUTIVE COMMITTEE
|
Sujata Dayal, JD
Independent Board Director, Emergent BioSolutions; Senior Advisor
JJ Kuhn, JD
Senior Vice President and Chief Ethics & Compliance Officer, Solventum
Mona Peterson Rosow, JD, MPH
Vice President, Global Risk, Ethics & Compliance Officer, Mozarc Medical
Tara Shewchuk, JD, LLM
Senior Vice President, Chief Privacy, Integrity & Compliance Officer, Medtronic
Daniel Spicehandler, JD
Vice President Compliance, Commercial Divisions, Stryker
|
|
GRANTORS
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
EXHIBITORS
|
|
|
Achsah Warren, MSJ
Vice President Compliance, Sumitomo; Fmr Vice President Compliance, Urovant; Fmr Senior Compliance Manager, Allergan, Irvine, CA |
Kelly Willenberg, MBA, DBA, CHC, CHRC
Chief Executive Officer, Kelly Willenberg & Assocs.; Board & Second Vice Chair, Health Care Compliance Association, Greenville, SC |
Elizabeth Weiss, JD
VP, Chief Compliance & Privacy Officer, Invivyd; Fmr Head of Compliance for Americas & EMEA, Lupin; Fmr Assistant GC, Pfizer, Livingston, NJ |
Amy Wilson, MBA, MSJ
VP & CCO, Esperion; Fmr Head of US Compliance, MorphoSys; Fmr Director, Enterprise Compliance, Alexion, Boston, MA |
Suki Wiltman
Vice President, Global Ethics & Compliance, Ipsen; Fmr Business Partner, Governance, Ethics & Compliance, GSK, Toronto, Canada
|
Katie Winson, MS
Director, Ethics & Compliance Business Partner, Jazz; Fmr Senior Manager, Monitoring, US & Global Compliance, Celgene, Carlsbad, CA |
Stacy E. Yeung, JD
VP & GC, SELLAS; Fmr Assistant General Counsel, Arena Pharma; Fmr Deputy General Counsel, DBV Technologies, New York, NY |
Olga Zinavenka, CPA, MBA
Head of Compliance Operations, Keenova; Fmr Executive Director, Head of Compliance Operations, Endo, Paoli, PA
|
|
FORMER GOVERNMENT OFFICIALS
|
Corey R. Amundson, JD
Partner, King & Spalding; Fmr Head, Public Integrity Section, US DOJ; Fmr Acting US Attorney, Middle District of Louisiana, Washington, DC |
David M. Blank, JD
Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC |
Jennifer L. Bragg, JD
Partner, Latham and Watkins; Fmr Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC |
Hui Chen, JD
Co-Founder, Culture. Data. Ethics; Fmr Compliance Counsel Expert, US DOJ; Fmr Assistant General Counsel, Pfizer, Honolulu, HI |
Deborah A. Curtis, JD
Partner, Arnold & Porter; Fmr Deputy GC, CIA; Fmr Deputy Chief, Counterespionage, US DOJ, Washington, DC
|
Corey R. Amundson, JD
Partner, King & Spalding; Fmr Head, Public Integrity Section, US DOJ; Fmr Acting US Attorney, Middle District of Louisiana, Washington, DC |
David M. Blank, JD
Partner, Arnall, Golden, Gregory; Fmr Senior Counsel, HHS; Fmr Special AUSA, Southern District Mississippi, Washington, DC |
Jennifer L. Bragg, JD
Partner, Latham and Watkins; Fmr Associate Chief Counsel for Enforcement, Office of Chief Counsel, US FDA, Washington, DC |
Hui Chen, JD
Co-Founder, Culture. Data. Ethics; Fmr Compliance Counsel Expert, US DOJ; Fmr Assistant General Counsel, Pfizer, Honolulu, HI |
Deborah A. Curtis, JD
Partner, Arnold & Porter; Fmr Deputy GC, CIA; Fmr Deputy Chief, Counterespionage, US DOJ, Washington, DC
|
Greg Demske, JD
Partner, Goodwin Procter; Fmr Chief Counsel, Office of Inspector General, US HHS, Washington, DC |
Edward Diskant, JD
Partner, McDermott Will & Schulte; Fmr AUSA, Southern District of New York, US DOJ, New York, NY |
Sarah A. Franklin, JD
Partner and Vice-Chair, Life Sciences Investigations Practice, Covington & Burling; Fmr Attorney, US FTC, Washington, DC |
Gregory T. Garcia
Executive Director, Cybersecurity Working Group, Health Sector Coordinating Council; Fmr Assistant Secretary for Cybersecurity, US DHS, Washington, DC |
Gejaa T. Gobena, JD
Partner, Hogan Lovells Cadwalader; Fmr Deputy Chief, Fraud Section, Criminal Division, US Department of Justice, Washington, DC
|
Christine Gordon, JD
VP, Risk, Assurance, & Compliance and CCO, Olympus; Fmr Assistant District Attorney, Philadelphia DA's Office, Bethlehem, PA |
Adam Greene, JD, MPH
Partner & Co-chair, HIPAA Practice, Davis Wright Tremaine; Fmr Senior HIT & Privacy Specialist, OCR, HHS, Washington, DC |
Kristie Gurley, JD
Partner Covington & Burling; Fmr Counsel, Office of the General Counsel, CMS Division, US Department of HHS, Washington, DC |
Sarah M. Hall, JD
Partner, Member of the Firm, Epstein Becker Green; Fmr Trial Attorney, Fraud Section, Criminal Division, US DOJ, Washington, DC |
Christina Hud, JD
Senior Counsel, Global Investigations, Pfizer; Fmr Health Care Fraud Acting Unit Chief & Senior Trial Counsel, US Attorney's Office, District of New Jersey, US DOJ, New York, NY
|
Michelle Jerrett, JD
Regional Head of Investigations & Monitoring, NA, Sanofi; Fmr AUSA, US Attorney's Office, District of Massachusetts, US DOJ, Cambridge, MA |
Stewart Kameen, JD
Partner, Davis Wright Tremaine; Fmr Senior Counsel, Industry Guidance Branch, OIG, HHS, Washington, DC |
Shannon Kelley, JD
EVP, Chief Legal Officer, Madrigal; Fmr AUSA & Deputy Chief of Litigation, US Attorney's Office District of Massachusetts, Boston, MA |
John Kelly, JD
Partner & Chair, Healthcare Practice, Barnes & Thornburg; Fmr Asst. Chief for Health Care Fraud, Criminal Division, US DOJ, Washington, DC |
Barbara A. Leaf, JD
Senior Int'l Advisor, Arnold & Porter; Fmr Special Assistant to the President; Fmr US Ambassador, UAE, Washington, DC
|
Christine Moundas, JD
Healthcare & Data Partner & Co-Head, Digital Health Initiative, Ropes & Gray; Fmr Analyst, OIG, US HHS, New York, NY |
Preeya Noronha Pinto, JD
Partner, DLA Piper; Fmr Acting General Counsel, US Department of Health and Human Services, Washington, DC |
Kenneth A. Polite, Jr, JD
Partner & Global Co-leader, White Collar Defense, Sidley Austin LLP; Fmr Assistant Attorney General, Criminal Division, US DOJ, Washington, DC |
Lisa M Re, JD
Partner, Life Sciences, Arnold & Porter; Fmr Assistant Inspector General for Legal Affairs, OIG, US HHS, Washington, DC |
Angela Schwartz, JD
Senior Principal, Global Commercial Compliance Consulting Leader, IQVIA; Fmr Special Assistant District Attorney, Montgomery County DA's Office, Philadelphia, PA
|
David J. Scott, MS
Managing Director, EY; Fmr Assistant Director, Counterterrorism, & Head, Operations Branch, National Cyber Investigative Joint Task Force, FBI, Leesburg, VA |
Diane Seol, JD
Of Counsel, Choate Hall & Stewart; Fmr AUSA, Affirmative Civil Enforcement Unit, US Attorney's Office, District of Massachusetts, Boston, MA |
Michael L. Shaw, JD
Global Head of Compliance, Privacy and Risk, ZS; Fmr VP & CO, GlaxoSmithKline; Fmr Senior Counsel, OIG US HHS, Princeton, NJ |
Amanda Strachan, JD
Partner, WilmerHale; Fmr AUSA & Chief, Criminal Division, US Attorney's Office, District of Massachusetts, US DOJ, Boston, MA |
Julie K. Taitsman, MD, JD
Managing Director, BDO, US; Fmr CMO, HHS OIG; Fmr Special Counsel, US Senate Committee on Finance, Washington, DC
|
Jane H. Yoon, JD
Partner, Litigation Department, Paul Hastings; Fmr Assistant United States Attorney, US Attorney's Office, New Jersey, New York, NY |
Heather Young, JD
Senior Director, Compliance Officer, Global Business Partner, Olympus; Fmr Philadelphia Assistant DA, Center Valley, PA
|
|
COMPLIANCE EXPERTS, ADVISORS AND COUNSEL
|
Warren T. Allen II, JD
Principal, Miles & Stockbridge, Washington, DC |
David Amendola
Director, Life Sciences, Resolution Economics; Fmr Global Compliance, ConvaTec, New York, NY |
Eliza L. Andonova, JD
Partner, Global Regulatory, Hogan Lovells Cadwalader, Washington, DC |
Minna Bak, MBA
Managing Director, HELIO, Boston, MA |
Brett Barlag, MBA
Senior Managing Director, Healthcare Risk Management and Advisory, FTI Consulting, New York, NY
|
For the complete list of speakers, click here
|
NEW THIS YEAR: FEATURING 5 IN-DEPTH, HALF-DAY, AFTERNOON
FOCUSED SESSIONS, 1:00-5:30 PM ON TUESDAY 10/13
(Included in your Congress registration.)
|
Focused Session 1: Whistleblower Complaints: From Hotline to Resolution: Managing Internal Investigations, Whistleblower Risk & Escalation Decisions
- Explore leading practices for managing hotline complaints, conducting effective internal investigations,
assessing whistleblower risk, making escalation decisions, and navigating today's evolving enforcement environment.
- Featuring a Qui Tam Counsel Roundtable
Focused Session 2: Pharmaceutical and Medical Device Advanced Privacy and Security/Cybersecurity Updates
- Gain practical insights into the latest privacy, cybersecurity, and data protection developments impacting
life sciences organizations, including advanced compliance strategies and emerging regulatory expectations.
- Featuring Presentations by International Association of Privacy Professionals & International Pharma & Medical Device Privacy Consortium
Focused Session 3: Managing Medical-Commercial Interactions: Strategic Collaboration, Evolving Roles & Risk-Based Governance
- Examine how leading organizations are strengthening collaboration between Medical Affairs and Commercial while
maintaining Medical independence, managing evolving field-based roles, and implementing effective governance models.
- Featuring Have We Become Too Restrictive? Rethinking Medical-Commercial Governance for the Next Era
Focused Session 4: AI in Action: Real-World Compliance Case Studies from the Front Lines of AI Use in Life Science Compliance Departments
- Hear directly from compliance leaders who are using artificial intelligence to enhance monitoring, investigations,
policy development, training, and other compliance activities through practical, real-world case studies.
- Featuring the Health Care Compliance Association Presents: Advanced Strategies in Using AI to Monitor and Improve Compliance
Focused Session 5: Government Pricing Fundamentals for Compliance Officers: Navigating Today's Evolving Pricing & Contracting Landscape
- Build a foundational understanding of government pricing while exploring the latest developments affecting
pricing, contracting, reimbursement, and compliance in today's rapidly changing regulatory environment.
- Featuring session on the new world of tariffs, mist favored nations, TrumpRX, Medicare drug price negotiation etc.
|
|
FOR E-MAIL ADDRESS CHANGE, ADD OR DELETE REQUESTS
|
For changes or additions, please email your request to: listmgr@PharmaUpdateNewsService.com.
For removal of your e-mail address, please click the link below for "SafeUnsubscribe" to automatically remove your address from the list.
|
|
|
|
